gallstones glp 1 GLP-1 Medications and Gallstones: Safety Guide Gallstones and GLP-1 Therapy: What

This was subsequently updated in Dec 2020 to include liraglutide for the treatment of obesity in adolescents between 12 to 17 years of age The starting dose of liraglutide is 0.6 mg once each day for 1 week and increased weekly to a maintenance dose of 3 mg once each day

There is no direct evidence that IGF-1 peptides cause cancer, but because IGF-1 promotes cellular proliferation , individuals with a history of cancer or pre-cancerous conditions should avoid use unless under medical supervision

However, as with any medical therapy, there may be situations where discontinuing the medication becomes necessary or desirable

Be sure to stay tuned for the second part of this series that explains why phosphatidylcholine (PTC) is often used in conjunction with chelation therapy.